Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Invested Capital (2019 - 2025)

Historic Invested Capital for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $26.3 million.

  • AVITA Medical's Invested Capital rose 48533.01% to $26.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.3 million, marking a year-over-year increase of 48533.01%. This contributed to the annual value of $26.3 million for FY2025, which is 48533.01% up from last year.
  • AVITA Medical's Invested Capital amounted to $26.3 million in Q4 2025, which was up 48533.01% from $35.8 million recorded in Q3 2025.
  • AVITA Medical's Invested Capital's 5-year high stood at $118.9 million during Q1 2021, with a 5-year trough of -$9.9 million in Q2 2025.
  • In the last 5 years, AVITA Medical's Invested Capital had a median value of $65.8 million in 2023 and averaged $59.8 million.
  • Over the last 5 years, AVITA Medical's Invested Capital had its largest YoY gain of 48533.01% in 2025, and its largest YoY loss of 14136.32% in 2025.
  • Over the past 5 years, AVITA Medical's Invested Capital (Quarter) stood at $104.6 million in 2021, then fell by 19.01% to $84.7 million in 2022, then crashed by 42.11% to $49.1 million in 2023, then crashed by 90.83% to $4.5 million in 2024, then skyrocketed by 485.33% to $26.3 million in 2025.
  • Its last three reported values are $26.3 million in Q4 2025, $35.8 million for Q3 2025, and -$9.9 million during Q2 2025.